SCHEMBL6050002

SCHEMBL6050002

C=CCC(CC(CC=C)C(=O)O)C(=O)O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 11/20 0.75
GRIK2 Q13002 11/20 0.75
CPA1 P15085 1/20 0.59
CYP2C19 P33261 1/20 0.43
CHRM1 P11229 1/20 0.36
AKR1A1 P14550 1/20 0.36
CHRM3 P20309 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
ADRA1A P35348 1/20 0.36
HRH1 P35367 1/20 0.36
DRD3 P35462 1/20 0.36
SLC6A3 Q01959 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
SLC1A1 P43005 2/20 0.36
ABCC4 O15439 1/20 0.36
MAPT P10636 1/20 0.36
TBXAS1 P24557 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL891727 0.92 GRIK1 (0.64) GRIK1GRIK2CPA1CYP2C19CHRM1
SCHEMBL4795102 0.89 GRIK1 (0.62) GRIK1GRIK2CPA1CYP2C19SLC1A1
SCHEMBL7305997 0.89 GRIK1 (0.62) GRIK1GRIK2CPA1CYP2C19SLC1A1
SCHEMBL1885655 0.89 GRIK1 (0.62) GRIK1GRIK2CPA1CYP2C19SLC1A1
SCHEMBL15312401 0.87 GRIK1 (1.00) GRIK1GRIK2SLC1A1SLC1A3SLC1A2
SCHEMBL594100 0.87 GRIK1 (1.00) GRIK1GRIK2SLC1A1SLC1A3SLC1A2
SCHEMBL7751545 0.87 GRIK1 (1.00) GRIK1GRIK2SLC1A1SLC1A3SLC1A2
SCHEMBL594101 0.87 GRIK1 (1.00) GRIK1GRIK2SLC1A1SLC1A3SLC1A2
Hydrochloric Acid SCHEMBL9087042 0.85 GRIK1 (0.96) GRIK1GRIK2SLC1A1SLC1A3SLC1A2
Hydrochloric Acid SCHEMBL9087046 0.85 GRIK1 (0.96) GRIK1GRIK2SLC1A1SLC1A3SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1193293-B1 Resin composition KYOWA YUKA KK (JP) 2006-03-01 EP claimed
US-20050043445-A1 Solution type coatings KYOWA HAKKO CHEMICAL CO LTD 2005-02-24 US claimed
EP-1475422-A1 SOLUTION TYPE COATINGS Kyowa Hakko Chemical Co., Ltd. (JP) 2004-11-10 EP claimed
US-6512057-B2 Resin composition KYOWA YUKA CO., LTD. (JP) 2003-01-28 US claimed
US-20020061942-A1 Resin composition KYOWA YUKA CO., LTD. (JP) 2002-05-23 US claimed
EP-1193293-A1 Resin composition Kyowa Yuka Co., Ltd. (JP) 2002-04-03 EP claimed
US-9440905-B2 Polymerizable gemini dicarboxlate surfactants and lyotropic liquid crystals and membranes made therefrom WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2016-09-13 US disclosed
US-20130190417-A1 POLYMERIZABLE GEMINI DICARBOXLATE SURFACTANTS AND LYOTROPIC LIQUID CRYSTALS AND MEMBRANES MADE THEREFROM WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2013-07-25 US disclosed
EP-1193293-B1 Resin composition KYOWA YUKA KK (JP) 2006-03-01 EP disclosed
US-20050043445-A1 Solution type coatings KYOWA HAKKO CHEMICAL CO LTD 2005-02-24 US disclosed
US-20050043445-A1 Solution type coatings KYOWA HAKKO CHEMICAL CO LTD 2005-02-24 US disclosed
US-20050038224-A1 Polyester KYOWA HAKKO CHEMICAL CO., LTD. (JP) 2005-02-17 US disclosed
EP-1477505-A1 POLYESTER Kyowa Hakko Chemical Co., Ltd. (JP) 2004-11-17 EP disclosed
EP-1475422-A1 SOLUTION TYPE COATINGS Kyowa Hakko Chemical Co., Ltd. (JP) 2004-11-10 EP disclosed
EP-1475422-A1 SOLUTION TYPE COATINGS Kyowa Hakko Chemical Co., Ltd. (JP) 2004-11-10 EP disclosed
US-6512057-B2 Resin composition KYOWA YUKA CO., LTD. (JP) 2003-01-28 US disclosed
US-20020061942-A1 Resin composition KYOWA YUKA CO., LTD. (JP) 2002-05-23 US disclosed
EP-1193293-A1 Resin composition Kyowa Yuka Co., Ltd. (JP) 2002-04-03 EP disclosed
JP-2002097256-A RESIN COMPOSITION KYOWA YUKA CO LTD 2002-04-02 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130190417-A1 POLYMERIZABLE GEMINI DICARBOXLATE SURFACTANTS AND LYOTROPIC LIQUID CRYSTALS AND MEMBRANES MADE THEREFROM SGMS1, SGMS2, DDOST GRIK1 966/4885GRIK2 850/4885CPA1 3913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.